Newsroom
Zhifei and GSK reached strategic cooperation, adding a new blockbuster...
Zhifei and GSK reached strategic cooperation, adding a new blockbuster product
2023-10-12
On October 8, 2023, Chongqing Zhifei Biological Products Co., Ltd. (hereinafter referred to as "Zhifei") and GlaxoSmithKline (GSK Biologica...
see details 》
Zhifei Longcom Recombinant COVID-19 Vaccine Receives Marketing Approva...
Zhifei Longcom Recombinant COVID-19 Vaccine Receives Marketing Approval in Kenya
2022-12-23
On December 22, the Company's Recombinant COVID-19 Vaccine (CHO Cell) was approved for marketing by the Pharmacy and Poisons Board (PPB) of...
Zhifei Longcom Passes EU QP Audit, An Acceleration in Zhifei’s Intern...
Zhifei Longcom Passes EU QP Audit, An Acceleration in Zhifei’s International Strategic Layout
2022-11-09
On November 8, 2022, the Recombinant COVID-19 Vaccine (CHO Cell) and the Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell) of An...
The Mayor of Hefei City, Ling Yun and the Leaders of Relevant Departments Visited the Company2020-10-28
On October 27, accompanied by leaders of relevant departments, the mayor of Hefei city, Ling Yun and the leaders of relevant departments vis...
ZhiFeiShengWu Listed in the "2020 China's Top 500 Manufacturing Private Enterprises"2020-09-11
On September 10, the 2020 China Top 500 Private Enterprises Summit hosted by the All-China Federation of Industry and Commerce was held in ...
Unveiling Ceremony of "Hunan Province Vaccine Clinical Trial Demonstration Base" Held2020-08-10
On the morning of August 10, the unveiling ceremony of Hunan Vaccine Clinical Trial Demonstration Base jointly constructed by Hunan CDC and ...
Zhifei Initiated Phase II Clinical Trials of Recombinant 2019-nCoV Vaccine2020-07-10
On July 10, the Phase II clinical trials of recombinant 2019-nCoV vaccine jointly developed by Zhifei Longcom, a wholly-owned subsidiary of ...
The Recombinant 2019-nCoV Vaccine Approved for Clinical Trials2020-06-23
Recently, National Medical Products Administration has officially released the clinical trial notification for the recombinant 2019-nCoV vac...